Age-associated insulin resistance (IR) and obesity-associated IR are two physiologically distinct forms of adult-onset diabetes. While macrophage-driven inflammation is a core driver of obesity-associated IR [1] [2] [3] [4] [5] [6] , the underlying mechanisms of the obesityindependent yet highly prevalent age-associated IR 7 are largely unexplored. Here we show, using comparative adipo-immune profiling in mice, that fat-resident regulatory T cells, termed fT reg cells, accumulate in adipose tissue as a function of age, but not obesity. Supporting the existence of two distinct mechanisms underlying IR, mice deficient in fT reg cells are protected against age-associated IR, yet remain susceptible to obesity-associated IR and metabolic disease. By contrast, selective depletion of fT reg cells via anti-ST2 antibody treatment increases adipose tissue insulin sensitivity. These findings establish that distinct immune cell populations within adipose tissue underlie ageing-and obesityassociated IR, and implicate fT reg cells as adipo-immune drivers and potential therapeutic targets in the treatment of age-associated IR.
mice in which T reg cells are selectively depleted (from 6.1% to 0.9%) from VAT 15 (fT reg knockout mice; Fig. 2a and Extended Data Fig. 2a, b) , although the depletion of PPARγ -positive T reg cells in tissues such as muscle and liver cannot be ruled out. This depletion is achieved without significantly altering the immune profiles of subcutaneous adipose tissue (SAT) or spleen (Extended Data Fig. 2c, d) . Importantly, the 6.8-fold VAT-specific loss of fT reg cells does not elicit any overt signs of systemic inflammation generally associated with T reg cell dysfunction. Aged fT reg knockout mice have normal-sized spleens and increased CD62L hi CD44 lo naive CD4 + T-cell populations compared to wild-type controls ( Fig. 2c and Extended Data Fig. 3a) . The normal intestinal histology provides additional evidence that the T reg cell population is not perturbed (Extended Data Fig. 3b, c) . Furthermore, no differences are observed in the levels of inflammatory cytokines, including TNFα , IL-1β , IL-6, IFNγ and IL-17, in the serum of aged fT reg knockout compared to control mice (Extended Data Fig. 3d) .
Notably, the selective loss of fT reg cells attenuates many of the hallmarks of age-associated metabolic dysregulation 16 . They weigh less than control mice and are leaner (decreased VAT and SAT adiposity) despite increased food consumption ( Fig. 2b-d ). In addition, the respiratory exchange ratio (Fig. 2e ), oxygen consumption ( Fig. 2f ) and core body temperature (Fig. 2g ) are increased in aged fT reg knockout mice compared to control mice. These marked improvements suggest that the age-associated metabolic phenotype is closely linked with VAT immune responses, and that in the aged setting, a reduction in fT reg cell numbers may be protective. Indeed, the AIPs of aged fT reg knockout mice are shifted towards those of young mice, as visualized by principal component analysis (Fig. 2h) .
Although the fT reg knockout phenotype is most pronounced in aged mice, a reduction in fT reg cell levels can also be found in obese fT reg knockout mice (Fig. 3a) . However, the beneficial metabolic effects of fT reg ablation are only significant in age-associated metabolic dysregulation, in which fasting serum glucose and insulin levels are significantly reduced (Fig. 3b, c and Extended Data Fig. 4a) . Furthermore, aged fT reg knockout mice display smaller glucose excursions during glucose tolerance tests and increased sensitivity during insulin tolerance tests compared to weight-matched control mice (Fig. 3e) . Again, these improvements in glucose homeostasis are observed only in aged mice; no significant differences are seen in young or obese fT reg knockout mice (Fig. 3d, f) , which is consistent with the largely unchanged AIPs of obese fT reg knockout mice (Extended Data Fig. 5a, b) .
Although fT reg cells were previously implicated in the insulinsensitizing function of the PPARγ agonists thiazolidinediones (TZDs) 15 , in our studies fT reg knockout mice display similar metabolic improvements to the TZD rosiglitazone as control mice. These beneficial effects of TZDs are evident with either direct treatment of obese mice (therapeutic intervention; Extended Data Fig. 6a-g ) or prophylactic treatment (drug intervention coincident with high-fat diet (HFD) feeding; Extended Data Fig. 6h-l) . Additionally, we find that the insulin-sensitizing effects of rosiglitazone precede the TZD-induced expansion of fT reg cells in HFD-fed mice (Extended Data Fig. 6m-q) . While intercolony variation cannot be ruled out, our findings do not support a significant role for fT reg cells in the therapeutic mechanism of action of TZDs.
Histologically, aged fT reg knockout VAT depots appear similar to control mice, and inflammatory processes such as macrophage crowning are observed at comparable frequencies ( Fig. 3g and data not shown). However, aged fT reg knockout VAT has increased levels of TNFα (Extended Data Fig. 7a ), increased expression of Vegfa (implicated in adipose remodelling and insulin sensitivity 17 ; Extended Data Fig. 7b ) and decreased expression of extracellular matrix genes (including collagen VI implicated in adipose tissue rigidity 18 , and the wound response gene Sparc; Extended Data Fig. 7b , c) compared to control tissue. Accompanying these changes, several proteases involved in extracellular matrix remodelling and angiogenesis (members of the ADAM, ADAMTS, MMP and CELA families) are differentially expressed (Extended Data Fig. 7b, d ). Of note, adipocytes from aged fT reg knockout mice are smaller than those in control mice (fT reg knockout: ~70% < 5,000 μ m 2 , control: ~41% < 5,000 μ m 2 ; Fig. 3h and Extended Data Fig. 4b ), and serum non-esterified free fatty acid levels are reduced to almost half those of control mice; both indicators of improved insulin sensitivity (Fig. 3i) . In addition, circulating levels of the adipokine resistin, which positively correlates with mouse IR, are reduced in the aged fT reg knockout mice 19, 20 (Fig. 3j) . Furthermore, aged fT reg knockout mice present with decreased hepatic steatosis, as determined histologically and by decreased fasting hepatic and serum triglyceride content (Fig. 3l-n) . In combination, these findings suggest that the loss of fT reg cells in adipose tissue alleviates many of the indications of age-associated IR in mice, a primary clinical manifestation of metabolic ageing.
To associate fT reg cells more directly with age-associated IR, we measured basal glucose uptake in adipose tissue ex vivo. Notably, VAT from fT reg knockout mice took up almost twice the amount of glucose as control tissue (Fig. 3k) . Conversely, expansion of fT reg cells in wild-type mice via treatment with IL-2-IL-2-monoclonal-antibody complex 21 abrogates basal glucose uptake in VAT by ~50% (Fig. 3o, p) . This inverse correlation between fT reg cell numbers and glucose uptake in adipose tissue supports a causal association between fT reg cells and IR during ageing.
Our findings of an association between fT reg cells and age-associated IR and metabolic ageing suggest that these cells are functionally distinct from splenic T reg cells. To investigate this notion, we compared the transcriptomes of T reg cells, as well as conventional CD4 + T (T conv ) cells, isolated from VAT and spleen. Comparative analyses revealed that while certain canonical genes are similarly expressed (for example, Foxp3, Ctla4 and Tigit), VAT and splenic T reg cells have discrete expression signatures, consistent with the suggested functional distinction. In particular, Pparg, Gata3 and Irf4 are selectively enriched in VAT but not splenic T reg cells 22 (Extended Data Fig. 8a ). Furthermore, unbiased comparative gene expression analyses combined with hierarchical clustering defined extensive fat-and splenicresidence clusters (1,142 and 1,431 genes, respectively) relative to , and lean and fat mass of control and fT reg knockout mice (~12 months, n = 8 per group). c, Mass of VAT, SAT and spleen in aged control and fT reg knockout mice (~15 months, n = 9 per group). d, Cumulative food consumption of control and fT reg knockout mice (~8-9 months, n = 8 per group). e, f, Average 24 h respiratory exchange ratio (RER) (e) and average oxygen consumption (VO 2 ) (f) of aged control and fT reg knockout mice (~11 months, n = 6 per group). g, Core body temperature of control and fT reg mice (~13 months, n = 9 per group). h, Principal component analysis of non-macrophage AIPs of young (12 weeks), aged (~15 months) and aged fT reg knockout (~15 months) mice (n = 9 per group). Data are mean ± s.e.m. * P < 0.05, * * P < 0.01, * * * P < 0.001, * * * * P < 0.0001, Student's t-test.
much smaller pan-T reg clusters 1 and 2 (56 and 162 genes, respectively). Transcriptionally, fT reg cells cluster more closely with fat T conv cells than splenic T reg cells ( ( Fig. 4b) . We posit that the transcriptional differences between fT reg cells and splenic T reg cells (found in the fT reg cell cluster of 1,049 genes) may provide a therapeutic route to manipulate fT reg cell populations selectively. The IL-33 receptor ST2, which lies within the fT reg cell cluster, has been recently implicated in effector T reg and in particular fT reg cell development 27,28 . Indeed, ST2 was ~60 and ~30 times more highly expressed in fT reg cells than in splenic T reg and fat T conv cells, respectively, consistent with the ImmGen database (http://www.immgen.org; Fig. 4e and Extended Data Fig. 8b ). Flow cytometry confirmed that ST2 is expressed on the cell surface of most fT reg cells, but on relatively few fat T conv cells, or splenic T reg or T conv cells (Fig. 4f, g ). Furthermore, VAT has ~25 times more ST2
+ fT reg cells than ST2 + fat T conv cells; a similarly trending ~10 times difference is observed in the spleen (Fig. 4h) .
To explore the therapeutic potential of the IL-33/ST2 signalling pathway, aged mice were initially injected with IL-33 (0.5 μ g intraperitoneally (i.p.) on days 0, 2 and 4, analysis on day 6) to expand the fT reg cell population (Fig. 4i-k) . In agreement with fT reg cell expansion driven by IL-2-anti-IL-2 treatment, mice injected with IL-33 display signs of IR (basal glucose uptake in VAT reduced to ~60% of control mice; Fig. 4l ). In the converse approach, acute treatment with an anti-ST2 antibody (200 μ g per mouse i.p. on days 0 and 2, analysis on day 3) is able to significantly deplete fT reg cells (~50% reduction), with a smaller percentage reduction of splenic T reg cells (Fig. 4m) . Notably, the partial depletion of fT reg cells achieved with acute anti-ST2 treatment coincides with an increase in insulin-stimulated glucose uptake in VAT (~25% increase in glucose uptake compared to control treated mice; Fig. 4n ), suggesting a link between fT reg cell depletion and increased adipose insulin sensitivity. Furthermore, this increase in insulin sensitivity is achieved without any signs of T conv cell activation associated with systemic T reg cell dysfunction (Extended Data Fig. 8c-e) .
As obesity and ageing often associate in humans, we challenged aged fT reg knockout and control mice with HFD. While initially protected against HFD-induced weight gain and associated metabolic dysregulation, the metabolic benefits attributed to the loss of fT reg cells were progressively lost over 8 weeks (Extended Data Fig. 9a-e) , further Cre Pparg fl/fl ) mice in young (12 weeks, control n = 6; fT reg KO n = 6), aged (~15 months, control n = 10; fT reg KO n = 10) and obese (control n = 6; fT reg KO n = 8) cohorts. b, Fasting serum glucose (b) and insulin levels (c) in control and fT reg knockout mice in young (12 weeks, control n = 9; fT reg KO n = 9), aged (36 weeks, control n = 9; fT reg KO n = 11) and obese (control n = 10; fT reg KO n = 10) cohorts. d-f, Glucose (left) and insulin (right) tolerance tests of control and fT reg knockout mice in young (12 weeks, control n = 8; fT reg KO n = 8) (d), aged (36-37 weeks, control n = 8; fT reg KO n = 9) (e) and obese (control n = 9; fT reg KO n = 10) (f) cohorts. g, Representative haematoxylin and eosin (H&E) staining of VAT (epididymal) from ~14-month-old control (n = 3) and fT reg knockout mice (n = 5). Scale bars, 50 μ m. h, Box and whisker plot of adipocyte size distribution in VAT from control (n = 3) and fT reg knockout mice (n = 3) (~14 months). i, Ad-libitum-fed serum non-esterified fatty acid (NEFA) levels in ~14-month-old control (n = 9) and fT reg knockout mice (n = 10). j, Serum resistin levels in ~14-month fasted control and fT reg knockout mice (n = 4 pooled samples (2 mice per sample) per group). k, Postprandial glucose uptake in VAT of aged control (n = 5) and fT reg knockout mice (n = 4). l, Representative H&E staining of liver from ~14-month-old control (n = 3) and fT reg knockout mice (n = 5). Scale bars, 200 μ m. m, Hepatic triglyceride levels in ~14-month-old control (n = 5) and fT reg knockout mice (n = 3). n, Fasting serum triglycerides in ~14-month-old control (n = 9) and fT reg knockout mice (n = 10). o, fT reg cells, expressed as percentage of total CD45.2 + cells, in control (PBS) and IL-2-anti-IL-2-treated mice (n = 3 mice per group). p, Relative glucose uptake in VAT of 16-week-old control and IL-2-anti-IL-2-treated mice (n = 4 mice per group). Data are mean ± s.e.m. * P < 0.05, * * P < 0.01, * * * P < 0.001, * * * * P < 0.0001, Student's t-test. suggesting that distinct pathophysiologies drive obesity-versus ageassociated IR.
Taken together, our data provide evidence that distinct adipoimmune populations orchestrate unique features of age-and obesity-associated IR. We show in the non-obese setting that Ppargpositive fT reg cells accumulate to unusually high levels (6.7%) as a function of age, exacerbating both the decline of adipose metabolic function as well as the rise in IR (Fig. 4o) . These results are in marked contrast to the increased role of M1 adipose tissue macrophages in metabolic dysfunction linked to obesity, coupled with a suppression of fT reg levels to 0.9%. Thus, these studies highlight contrasting roles of the immune compartment in contributing to key aspects of adipose health and disease.
Given the classical immune suppressive and anti-inflammatory nature of T reg cells, we speculate that the chronic inflammatory processes that drive obesity-associated IR seem unlikely to be driving age-associated IR. Indeed, there is increasing appreciation that maintaining a certain degree of inflammation is beneficial for adipose tissue remodelling and its metabolic function 29 . Failure to preserve an optimal immune state in the aged adipose tissue may directly contribute to metabolic disorders such as IR and age-associated diabetes. We suggest type IV diabetes as a designation for non-obese-dependent fT reg -driven metabolic disease of the elderly.
In this context, it is of particular significance that fT reg cells in aged adipose tissue express the cytokine receptor ST2 at ~30-60-fold higher levels than in other sites such as spleen, making the fT reg cell population sensitive to depletion via anti-ST2 treatment. While ST2 has been implicated in other physiological processes and immune cell types that may also affect glucose homeostasis, this simple fT reg cell depletion approach increases adipose tissue insulin sensitivity suggesting the potential of selective fT reg cell depletion therapy in the prevention of age-related IR.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. + of CD45 + population) (m) and ex vivo insulin-stimulated glucose uptake (n) in VAT from wild-type mice after anti-ST2 depleting antibody or isotype control treatment (~45 weeks, n = 4 mice per group). o, Adipo-immune model of metabolic ageing. Data are mean ± s.e.m. * P < 0.05, * * P < 0.01, * * *P < 0.001, * * * *P < 0.0001, &P = 0.053, %P = 0.056, Student's t-test. 
MethOds
Mice. All mice were housed in the specific pathogen-free facilities at The Salk Institute for Biological Studies or purchased from Taconic Biosciences. C57BL/6NTac mice were purchased from Taconic Biosciences for comparative AIPs or studies that required wild-type aged mice. Age-matched retired breeders were purchased for AIPs of aged adipose tissue, and dietinduced obese C57BL/6NTac mice were purchased for profiling of obese adipose tissue. fT reg knockout mice were generated by crossing Foxp3
Cre (Foxp3-IRES-YFP-Cre) 30 and ) and digested in stromal vascular isolation buffer (100 mM HEPES, pH 7.4, 120 mM NaCl, 50 mM KCl, 5 mM glucose, 1 mM CaCl 2 and 1.5% BSA) containing 1 mg ml −1 collagenase at 37 °C with intermittent shaking for 1.5 h. The suspension was then passed through a 100-μ m mesh to remove undigested clumps and debris. The flow-through was allowed to stand for 10 min to separate the floating adipocyte fraction and infranatant containing the stromal vascular fraction. The infranatant was removed while minimally disturbing the floating adipocyte fraction and centrifuged at 400g for 10 min. The pellet containing the stromal vascular fraction was washed once in 10 ml RPMI. The resultant isolated cells were subjected to FACS analysis. The following antibodies were used to assemble the adipo-immune profile. BioLegend: CD45. Body composition and adipocyte size analyses. Body composition was measured with an Echo MRI-100 body composition analyser (Echo Medical Systems). VAT (epididymal) was dissected, and the wet weight was determined. Adipose tissues were fixed in 10% formalin, sectioned, and stained in haematoxylin and eosin. An adipocyte cross-sectional area was determined from photomicrographs of VAT using ImageJ. In vivo metabolic phenotype analysis. Real-time metabolic analyses were conducted in a Comprehensive Lab Animal Monitoring System (Columbus Instruments). CO 2 production, O 2 consumption and ambulatory counts were determined for at least three consecutive days and nights after at least 24 h for adaptation before data recording. Principal component analysis of AIPs. Non-macrophage immune cell populations, described as percentage of the total CD45.2 + immune compartment, were inputted into MetaboAnalyst 3.0 (http://www.metaboanalyst.ca/ MetaboAnalyst/) for PCA. No normalizations, transformations, or scalings were implemented. Glucose homeostasis studies. Fasting was induced for 6 h, except for glucose tolerance tests, which were conducted after overnight fasting. Glucose (1-2 g kg , i.p.) was injected for glucose tolerance tests and insulin tolerance tests, respectively. Blood glucose was monitored using a Nova Max Plus glucometer. Histological analyses. Sections (4 μm) of fixed tissues were stained with haematoxylin and eosin according to standard procedures. Histopathological scores were graded on blinded samples for severity and extent of inflammation and morphological changes by a pathologist. Serum analyses. Blood was collected by tail bleeding or right atrial puncture. Non-esterified fatty acids (Wako) and triglycerides (Thermo) were measured using colorimetric methods. Serum insulin levels (Ultra Sensitive Insulin, Crystal Chem) were measured by ELISAs. Serum cytokine and metabolic hormone levels were analysed by the Luminex Bio-Plex system using the Mouse Cytokine 23-Plex Panel and Diabetes Panel, respectively, according to the manufacturer's instructions (Bio-Rad). Core body temperature. Mice were single housed, and core body temperature was measured with a clinical rectal thermometer (Thermalert model TH-5; Physitemp) during the middle of the light cycle. The probe was dipped in a room temperature lubricating glycerol before insertion. Ex vivo 2-DG uptake assays. Adipose tissue was dissected from mouse, cut into small pieces with scissors, washed and incubated for 30 min with Krebs-Ringer Bicarbonate HEPES buffer (KRBH, 120 mM NaCl, 4 mM KH 2 PO 4 , 1 mM MgSO 4 , 0.75 mM CaCl 2 , 30 mM HEPES and 10 mM NaHCO 3 , pH 7.4, supplemented with 1% fatty-acid-free BSA). For determination of exogenous insulin-stimulated 2-deoxy-d-glucose (2-DG) uptake, adipose was incubated in KRBH with 100-200 nM insulin for 20 min at 37 °C. Cold 2-DG and hot 2-DG-1,2-3 H(N) was added to incubated adipose tissue such that the final concentration of cold 2-DG was 0.1 mM and final quantity of hot 2-DG-1,2-3 H(N) was 0.1 μCi (assuming total reaction volume ~400 μ l). Adipose was further incubated for 20 min at 37 °C, then washed three times with PBS before being lysed by scintillation fluid. 2-DG uptake was determined by measuring scintillation counts normalized to adipose tissue mass used for assay. Nonspecific 2-DG uptake levels were determined by co-treating adipose tissue with cytochalasin B (0.1 μ M final concentration) with the addition of cold and hot 2-DG. IL-2-anti-IL-2 complex and IL-33 injections. IL-2-anti-IL-2 complexes were prepared by incubating 2 μ g of mouse IL-2 (Biolegend) with 10 μ g of anti-IL-2 antibody (JES6.1, Bioxcell) in a total volume of 200 μ l PBS for 30 min at 37 °C (amounts given per injection). Mice were injected i.p. three times (days 0, 1 and 2) and analysed on day 8. For IL-33 expansion assays, mice were injected i.p. with 0.5 μ g of recombinant mouse IL-33 in PBS (R&D systems) three times (days 0, 2 and 4) and analysed on day 6. PBS was used for control injections. RNA-Seq library generation. Total RNA was isolated from sorted cells or whole tissues using TRIzol reagent (Invitrogen) as per the manufacturer's instructions and treated with DNaseI (Qiagen) for 30 min at 22 °C. Sequencing libraries were prepared from 10-100 ng of total RNA using the TruSeq RNA sample preparation kit v2 (Illumina) according to the manufacturer's protocol. In brief, mRNA was purified, fragmented and used for first-and second-strand cDNA synthesis followed by adenylation of 3′ ends. Samples were ligated to unique adaptors and subjected to PCR amplification. Libraries were then validated using the 2100 BioAnalyzer (Agilent), normalized and pooled for sequencing. RNA-Seq libraries prepared from two biological replicates for each experimental condition were sequenced on the Illumina HiSeq 2500 using barcoded multiplexing and a 100-bp read length. High-throughput sequencing and analysis. Image analysis and base calling were done with Illumina CASAVA-1.8.2. This yielded a median of 29.9 M usable reads per sample. Short read sequences were mapped to a UCSC mm9 reference sequence using the RNA-Seq aligner STAR 33 . Known splice junctions from mm9 were supplied to the aligner and de novo junction discovery was also permitted. Differential gene expression analysis, statistical testing and annotation were performed using Cuffdiff 2 (ref. 34) . Transcript expression was calculated as gene-level relative abundance in fragments per kilobase of exon model per million mapped fragments and employed correction for transcript abundance bias 35 . RNA-Seq results for genes of interest were also explored visually using the UCSC Genome Browser. Hierarchical clustering. Differentially expressed gene names and corresponding FPKM values across samples were inputted into GENE-E (Broad Institute) for hierarchical clustering analysis (implemented one minus pearson correlation for sample and gene distance metrics and the average linkage method) and visualization. Gene cluster names were created to describe the gene expression characteristics within each cluster (that is, fat-residence cluster refers to the gene cluster in which genes are expressed at greater levels in T cells residing in fat. Fat-T reg cluster refers to the gene cluster in which genes are expressed highest in only the fT reg cells). In vitro suppression assay. fT reg cells were isolated from aged wild-type mice treated with IL-2-anti-IL-2 complexes to expand fT reg cell numbers, as described above with isolation conducted on day 6. Stromal vascular fractions were isolated from VAT as described above, and fT reg cells were sorted from stromal vascular fractions using the BD FACSAria instrument (Becton Dickinson), gating on CD45.2 + CD4 + CD25 + cells. CD45.1 + mice were used to isolate splenic responder T cells, which were purified by positive selection using CD4-specific Dynabeads (Invitrogen), followed by sorting on a BD FACSAria cell sorter, gating on CD45.1 + CD4 + CD25 − CD62L hi CD44 lo cells. Antigen-presenting cells were prepared from wild-type B6 splenocytes by T-cell depletion using Thy1-specific MACS beads. CFSE labelled effector T cells (5 × 10 4 cells well −1 ) were co-cultured with fT reg cells at the indicated ratio in the presence of irradiated (30 Gy) antigen-presenting cells (1 × 10 5 cells well −1 ) in 96-well plates in complete RPMI1640 medium supplemented with 10% FBS and CD3 antibody (1 μg ml −1 ). Cell proliferation and expansion index were determined 96 h later using the BD FACSAria instrument and analysed with the FlowJo software package (Tree Star). Cre population (n = 9 mice per group). b, Representative histology of gastrointestinal tract-duodenum, jejunum, ileum and colon (left to right) (n = 3 mice per group). There were no significant lesions observed or differences in inflammation, epithelial changes, or mucosal architecture between the two groups (H&E, original magnification, × 100). Scale bar, 50 μ m. c, Histopathology score in the small intestine and colon of fT reg knockout and control mice. The severity and extent of inflammation and epithelial changes as well as mucosal architecture were each graded on a score of 1 (minimal) to 5 (severe) and added to obtain an overall score over 20. There were minimal inflammatory changes with no significant differences between groups. d, Multiplex inflammation panel of serum from fT reg knockout and control mice (n = 4 pooled samples (3 mice per sample) per group). Data are mean ± s.e.m. * P < 0.05, * * * P < 0.001, Student's t-test. 
Letter reSeArCH

